ECBHM Legislation Flashcards

EU Law (193 cards)

1
Q

Legal milk quality requirements (EU2004/853) - Bulk milk SCC

A

<400,000 (geometric mean over 3 months of monthly samples)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Legal milk quality requirements (EU2004/853) - Total Plate Count (TBC)

A

<100,000 (geometric mean over two months of fortnightly samples)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

official controls on products of animal origin (EU) 2019/627- DETERMINATION OF ALKALINE PHOSPHATASE (to verify pasteurizzation)

A

< 350mU/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Regulation 853/2004: laying down specific hygiene rules for on the hygiene of foodstuffs

A

Milk for human consumption must come from cows free of tuberculosis, brucellosis, has to be cooled (8°C daily collection; 6°C if not collected daily), BMSCC and TPC, Alkaline phosphatase and peroxidase test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Protection and surveillance zone radius required for the five category A diseases (EU 2020/687) - Foot and Mouth Disease

A

Protection zone: 3 km; Surveillance zone: 10 km

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Protection and surveillance zone radius required for the five category A diseases (EU 2020/687) - Rinderpest

A

Protection zone: 3 km; Surveillance zone: 10 km

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Protection and surveillance zone radius required for the five category A diseases (EU 2020/687) - Rift Valley Fever

A

Protection zone: 20 km; Surveillance zone: 50km

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Protection and surveillance zone radius required for the five category A diseases (EU 2020/687) - Lumpy Skin Disease

A

Protection zone: 20 km; Surveillance zone: 50 km

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Protection and surveillance zone radius required for the five category A diseases (EU 2020/687) - Contagious Bovine Pleuropneumonia (Mycoplasma mycoides)

A

Protection zone: Establishment; Surveillance zone: 3 km

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Protection of animals at slaughter legislation (EU 1099/2009) - General requirements

A

Physical comfort and protection; Normal behaviour - no avoidable pain, fear; Not prolonged withdrawal of feed and water; Protected from interaction with other animals with could harm welfare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Protection of animals at slaughter legislation (EU 1099/2009) - Procedures which are prohibited

A

Suspending/hoisting conscious animal; Mechanical clamping or tying of feet; (Some exemptions for religious slaughter)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Protection of animals at slaughter legislation (EU 1099/2009) - Procedures which require certification of competence

A

Handling/care prior to restraint; Restraint for stunning/killing; Stunning and assessment of effective stun; Shackling, hoisting and bleeding of live animal; Slaughtering in accordance with religious practice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Protection of animals at slaughter legislation (EU 1099/2009) - Title of person responsible for monitoring of slaughterhouse operation

A

Animal Welfare Officer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Protection of farmed animal legislation (EU 98/58) (directive = EU sets goals, countries make national law) - Environmental factors which must be acceptable

A

Air circulation; Dust levels; Temperature; Relative humidity; Light - not dark or only artificial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Protection of farmed animal legislation (EU 98/58) - Requirements for - Staff, Inspections, Records

A

Staff - sufficient number, appropriate skills, knowledge, competence; Inspections - at least once daily; Records - all medical treatments, keep for 3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Properties of feedstuff for prevention of acidosis (EU 2020/354) (regulation = binding legislative act, all EU members)

A

Low levels of easily fermentable carbohydrates; High buffering capacity; (Maximum duration 2 months)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Properties of feedstuff for prevention of clinical/subclinical hypocalcemia (EU 2020/354)

A

Low DCAD - <0 mEq/kg DM (Duration - last 3 weeks before calving) OR Calcium binder (zeolite) (Duration - last 2 to 3 weeks before calving; 250-500g per cow per day) OR Rumen protected phytic acid (>6%) to provide 28-32g calcium per cow per day (Duration - last 4 weeks before calving) OR High calcium - Salts: chloride, sulphate, phosphate, carbonate, propionate, formate (minimum 50g per cow per day) - Calcium pidolate - 5.5g per cow per day OR Waxy leaf nightshade (provide 38-46 ug 1,25-dihydroxycholecalciferol per cow per day)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Properties of feedstuff for prevention of hypomagnesaemia (EU 2020/354)

A

High magnesium; Easily available carbohydrates; Moderate protein; Low potassium; (Feed for 3-10 weeks during fast grass growth)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Properties of feedstuff for prevention of ketosis (EU 2020/354)

A

Glucogenic energy sources - Propylene glycol - 250g/day OR Calcium/Sodium propionate 110g/day (or combination of both) (Duration - 3 weeks pre-calving to 6 weeks after calving)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Properties of feedstuff for prevention of urinary calculi (EU 2020/354)

A

Low phosphorus; Low magnesium; Acidifies urine; (Duration - up to 6 weeks, especially for intensively fed young animals)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Properties of feedstuff for stabilisation of water and electrolytes (EU 2020/354)

A

Easily absorbable carbohydrates; Sodium 1.7 - 3.5 g/L; Potassium 0.4 - 2 g/L; Chloride 1 - 2.8 g/L; Buffering capacity (SID) minimum 60 mmol/L; (Duration - 1 to 7 days); (Avoid milk if bicarbonate or citrate >40 mmol/L)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Properties of feedstuff for support of dietary transition (EU 2020/354) (3x mineral, 3x vitamin)

A

Selenium; Zinc; Copper; Vitamin A; Vitamin D; Vitamin E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Properties of feedstuff for support of oestrus and reproduction (EU 2020/354) (2x mineral, 3x vitamin)

A

Selenium; Zinc; Vitamin E; High Vitamin A/Beta-carotene; Vitamin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Properties of feedstuff for support of regeneration of hooves and skin (EU 2020/354) (1x mineral, 1x amino acid, 1x vitamin)

A

Zinc; Methionine; Biotin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Properties of feedstuff for support of skin and appendages (EU 2020/354)
Zinc (20 mg/kg); Copper +/- Iodine +/- Selenium; and/or Vitamin A +/- Vitamin B6 +/- Vitamin E and/or Methionine +/- Cystine +/- Biotin
26
Properties of feedstuff for support of weaning (EU 2020/354) (5x mineral, 3x vitamin)
Selenium; Zinc; Copper; Iodine; Manganese; Vitamin A; Vitamin D; Vitamin E
27
Regulation 1831/2003 on additives for us in animal nutrition
Categories of feed additives: technological, sensory, nutritional, zootechnical, coccidiostats
28
Medicated feed legislation (EU 2019/4) - regulation - Maximum duration of feed prescription for antibiotics
5 days
29
Medicated feed legislation (EU 2019/4) - Maximum duration of feed prescription for non-antibiotics
6 months
30
Medicated feed legislation (EU 2019/4) - Minimum proportion of ration if feeding medicated feed (excluding mineral supplements)
0.5
31
Maximum amount of iron in a bolus (as inert, non-bioavailable form) (EU 2020/354)
20% weight
32
Listed diseases that affect cattle in EU 2018/1629 (Amending EU 2016/429) (22)
Rinderpest; Rift Valley fever; Brucella abortus; Mycobacterium tuberculosis complex; Rabies; Bluetongue (serotypes 1 to 24); Echinococcus multilocularis; Epizootic hemorrhagic disease; Anthrax; Surra (Trypanosoma evansi); Ebola; Paratuberculosis; Japanese encephalitis; West Nile fever; Q fever; Lumpy skin virus; CBPP; IB/IPV; BVD; Genital campylobacteriosis; Trichomoniasis; EBL
33
EU legislation definition - ‘metaphylaxis’
Administration of a medicinal product to a group of animals after a diagnosis of clinical disease in part of the group has been established, with the aim of treating the clinically sick animals and controlling the spread of the disease to animals in close contact and at risk and which may already be subclinically infected
34
EU legislation definition - ‘prophylaxis’
Administration of a medicinal product to an animal or group of animals before clinical signs of a disease, in order to prevent the occurrence of disease or infection
35
Diseases which countries can be officially listed as "disease-free" in EU (EU 2020/2002) (7)
Brucella abortus (+ B. melitensis, B. suis); Mycobacterium Tuberculosis Complex (TB); Enzootic Bovine Leukosis; BoHV-1 - IBR/IPV; BVD; Rabies; Bluetongue
36
Calf legislation (EU 2008/119) - directive - Age at which fibrous feed and fresh water must be available
2 weeks old
37
Calf legislation (EU 2008/119) - Age until bedding material no longer compulsory
2 weeks
38
Calf legislation (EU 2008/119) - Definition of calf
Bovine up to 6 months old
39
Calf legislation (EU 2008/119) - Enough iron in diet to ensure blood haemoglobin at least ...
4.5 mmol/L
40
Calf legislation (EU 2008/119) - Environmental factors which must be suitable
Air circulation; Dust levels; Temperature; Humidity; Gas content; Light
41
Calf legislation (EU 2008/119) - Holdings excluded from legislation
If less than 6 calves or Cow and calf housed together
42
Calf legislation (EU 2008/119) - Maximum age for individual pens
8 weeks old
43
Calf legislation (EU 2008/119) - Maximum duration between birth and colostrum feed
6 hours (but ASAP)
44
Calf legislation (EU 2008/119) - Minimum amount of fibrous food by age (<2 weeks, 2 - 8 weeks, 8 - 20 weeks)
<2 weeks - 0 g; 2 - 8 weeks - 50 g; 8 - 20 weeks - 250 g
45
Calf legislation (EU 2008/119) - Minimum frequency of feeding
Twice daily
46
Calf legislation (EU 2008/119) - Minimum size of individual pens
Width - height of calf at withers; Length - body length + 10%
47
Calf legislation (EU 2008/119) - Space requirements in group housing (<150 kg, 150 - 220 kg, >220 kg)
<150 kg - 1.5 sqm; 150 - 220 kg - 1.7 sqm; >220 kg - 1.8 sqm
48
Category A diseases in European law (EU 2020/687) (5)
Foot and Mouth disease; Rinderpest; Rift Valley fever; Lumpy skin disease; Contagious bovine pleuropneumonia (Mycoplasma mycoides)
49
Protection of animals during transport EU Regulation 1/2005
General condition for the transport of animals (fit for the journey)
50
Definitions, Transport documentation
51
Protection of animals during transport EU Regulation 1/2005 - contents
Planning obligations for the transport of animals, Transporters , inspection, Keepers, Assembly centers, requirements for transporteur authorization
52
RASFF
Rapid Alert System for Food and Feed
53
ADIS
Animal Disease Information System
54
Approved biocides for skin disinfection (e.g. DD control)
Formalin; Glutaraldehyde; Peracetic acid; Formic acid; Salicylic acid
55
Maximum formaldehyde concentration in environment
0.3ppm
56
Special Provisions For Bulls Kept For Breeding - isolation
Pens or standings for bulls should be sited so as to allow the bull sight and sound of farm activity
57
Special Provisions For Bulls Kept For Breeding - sleeping area
individual accommodation for an adult bull of average size kept in a pen should include a sleeping area of not less than 16 m2 . For bulls heavier than 1000 kg, the sleeping area should be not less than 1 m2 for each 60 kg liveweight
58
Special Provisions For Bulls Kept For Breeding - service area
The service area should be designed, equipped and maintained so as to avoid injuries to bull and cow
59
Special Provisions For Bulls Kept For Breeding - exercise
Bulls shall be allowed sufficient exercise
60
61
Maximum duration of carcass transport after on-farm slaughter in truck not chilled
2 hours
62
Pasteurisation temperature if heated for 15 seconds
72 Deg C
63
Pasteurization temperature if heated for 30 minutes
63 Deg C
64
Outcomes to indicate effective stunning (before killing)
Collapse; Apnoea; Tonic seizures; No corneal/palpebral reflex; No vocalization; Fixed eye position
65
Outcomes to indicate effective killing
Relaxed muscle tone; No breaths; No corneal/palpebral reflex; Dilated pupils; No heartbeat
66
EFSA - maximum age of rubber ring castration
2 months (cut off scrotum after 8 - 9 days)
67
EFSA - anaesthesia/analgesia requirement for disbudding/dehorning
Local anesthetic + systemic analgesia for 2 days
68
ESFA - minimum % physically effective fibre in ration of finishing cattle
Rations for finishing cattle should include at least 15 % physically effective fibre to reduce the risk of bloat, SARA and its sequelae
69
EFSA - maximum amount of urea in ration
<1% DM ( or 0.3g/kg BW/day)
70
EFSA - welfare consequences during slaughter
Heat or cold stress; Fatigue; Prolonged thirst or hunger; Impeded or restricted movement; Inability to rest; Social stresses; Pain, fear, distress
71
EU Reg 1099/2009 - use of non-penetrative captive bolt in ruminants
<10kg (i.e. not permitted in bovines)
72
EU Reg 1099/2009 - minium current for stunning bovines < 6 months old
1.25 amps
73
EU Reg 1099/2009 - minium current for stunning bovines > 6 months old
1.28 amps
74
EU Reg 1/2005 - restrictions on animal transport
Cannot transport if: unable to move without pain; severe open wound or prolapse; >90% gestation; neonate with wet navel
75
EU Reg 1/2005 - maximum distnace for transport of cavles <10 days old
100km
76
EU Reg 1/2005 - milking frequency for lactating cows not transported with offspring
Every 12 hours
77
EU Reg 1/2005 - maximum duration of transport before 1 hour rest required - pre-weaning calves
9 hours
78
EU Reg 1/2005 - maximum duration of transport before 1 hour rest required - weaned cattle
14 hours
79
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - Prescription -scientific knowledges
The prescription and dispensation of antimicrobials must be justified by a veterinary diagnosis in accordance with the current status of scientific knowledge
80
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - Prescirption on a diagnosis made
the prescription should be based on a diagnosis made following clinical examination of the animal by the prescribing veterinarian. Where possible, antimicrobial susceptibility testing should be carried out to determine the choice of antimicrobial
81
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - Methaphylaxis
Antimicrobial metaphylaxis ( 2 ) should be prescribed only when there is a real need for treatment
82
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - Routine prohyylaxis
Routine prophylaxis must be avoided.
83
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - Isolation and individual treatment
Sick animals should be isolated and treated individually
84
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - Narrow spectrum AB
A narrow-spectrum antimicrobial should always be the first choice unless prior susceptibility testing
85
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - reasons of the recurring
efforts should be made to eradicate the strains of the microorganisms by determining why the disease is recurring, and altering the production conditions, animal husbandry and/or management.
86
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - Used of AB prone to resistance
Use of antimicrobial agents prone to propagate transmissible resistance should be minimised.
87
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - Off- label used
The off-label use (cascade) of the compounds referred to above for non-food-producing animals (e.g. pets and animals used for sports) should be avoided and strictly limited to very exceptional cases, e.g. where there are ethical reasons for doing so, and only when laboratory antimicrobial susceptibility tests have confirmed that no other antimicrobial would be effective
88
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - instruction in veterinarian prescription
Antimicrobial treatment must be administered to animals according to the instructions given in the veterinarian's prescription
89
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - reassessment of the therapy
The need for antimicrobial therapy should be reassessed on a regular basis
90
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - alternative strategies for controlling diseases
When possible, alternative strategies for controlling disease that have been proven to be equally efficient and safe (e.g. vaccines) should be preferred over antimicrobial treatment
91
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - issues critically important antibiotics
use on e basis of antimicrobial susceptibility testing and relevant epidemiological data, no non-critically important effective antimicrobial available, Justified and recorded. No other alternative are available to avoid suffering of diseased animals
92
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - prophylaxis in clves
avoiding the prophylactic use of antimicrobials in new-born calves (e.g. antimicrobials added to milk replacers) by instead implementing good farming practices (e.g. to ensure high standards of hygiene);
93
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - preventive strategies
developing preventive strategies (e.g. vaccinations and feeding colostrum to calves), especially for the allotment of veal calves and beef cattle;
94
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - systematic tratment at drying-off
avoiding the systematic treatment of cows at drying-off, and considering and implementing alternative measures on a case-by-case basis;
95
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - hygiene and good farm practices
establishing thorough hygiene measures and good farm practice and management strategies to minimise the development and spread of mastitis in dairy cows;
96
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - rapid diagnostic test
promoting the use of rapid diagnostic tests (e.g. standardised tests with chromogenic media) for identifying mastitiscausing pathogens, in order to minimise the use of both intramammary and injectable antimicrobials in milking cows;
97
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - waste milk with antimicrobials
avoiding feeding calves with waste milk from cows that have been treated with antimicrobials.
98
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - hygiene and biosecurity
implementing hygiene and biosecurity measures
99
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - protocols for prevention
producing clear protocols for the prevention of infectious diseases and infection control and hygiene; making these available on farms;
100
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - husbandry systems
improving husbandry systems by providing appropriate housing, ventilation and environmental conditions for animals and appropriate and clean facilities during transport (e.g. the lairage area and vehicles);
101
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - unknow health status of new animals
establishing integrated production systems which avoid the need to buy and mix animal populations and to transport animals with unknown disease status;
102
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - stressful situations
avoiding stressful situations which can weaken animals' immune systems and make them more susceptible to infections, e.g. limiting the transport of animals, minimising transport time and ensuring that the recommended animal population density is adhered to (i.e. avoiding overcrowding);
103
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - implementing zootehnical treatments
implementing other zootechnical treatments to minimise disease and decrease use of antimicrobials;
104
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - herd specific plans
introducing herd-specific health plans designed to achieve a consistent stepwise improvement in herd health and avoiding and discouraging health programmes in which animals are systematically treated with antimicrobials prophylactically;
105
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - controls programmes by vaccination
implementing programmes to control specific animal diseases (both viral and bacterial) by means of vaccination;
106
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - alternative to antimicrobials
using scientifically proven, effective and safe alternatives to antimicrobials;
107
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - feed and water
using only safe, high-quality feed and water;
108
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - incentive for farmers
providing incentives to farmers to encourage them to adopt effective preventive measures, to improve animal health and welfare standards and to monitor pathogens and their sensitivity at herd level, with the ultimate objective of ensuring evidence-based use of antimicrobials in individual herds
109
Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) - Prescriber
Prescriber: veterinnarian familiar with the history of the herd. The primary responsibility for the prudent use of antimicrobials lies with the prescriber and the person administering the antimicrobials.
110
official controls on products of animal origin (EU) 2019/627 article 11- paragraph 1 ante mortem
All animals shall be subjected to ante-mortem inspection before slaughter
111
official controls on products of animal origin (EU) 2019/627 article 11- paragraph 2 ante mortem
Ante-mortem inspection shall take place within 24 hours of arrival of the animals at the slaughterhouse and less than 24 hours before slaughter.
112
official controls on products of animal origin (EU) 2019/627 article 11- paragraph 3 ante mortem
health and welfare compromised, any condition, abnormalities or disease that make the fresh meat unfit for human consumption, of the use of prohibited or unauthorised substanc (medical producs, chemical residues, contaminants)
113
official controls on products of animal origin (EU) 2019/627 article 11- paragraph 4 ante mortem
verification of food business operators' compliance with their obligation to ensure that animals have a clean hide, skin or fleece, so as to avoid any unacceptable risk of contamination
114
official controls on products of animal origin (EU) 2019/627 article 11- paragraph 5 ante mortem
The official veterinarian shall carry out a clinical inspection of all animals that the food business operator or an official auxiliary may have put aside for a more thorough ante-mortem inspection
115
official controls on products of animal origin (EU) 2019/627 article 12- paragraph 1 post mortem general
post-mortem inspection: without delay after slaughter; check all external surfaces, including those of body cavities of carcases; pay particular attention to the detection of zoonotic diseases and animal diseases (del reg.2016/429) laid down in Regulation (EU) 2016/429
116
official controls on products of animal origin (EU) 2019/627 article 15- paragraph 1 post mortem bovine over 8 months
post-mortem inspection split lengthways into half carcases down the spinal column; may also require any head to be split lengthways
117
official controls on products of animal origin (EU) 2019/627 article 16- emergency slaughter
carcase shall be subjected to post-mortem (ASAP)
118
official controls on products of animal origin (EU) 2019/627 article 18- young bovine animals - paragraph 1 ages
animals under eight months old; and animals under 20 months old if reared without access to pasture land during their whole life in an officially tuberculosis-free Member State or region of a Member State
119
official controls on products of animal origin (EU) 2019/627 article 18- young bovine animals - paragraph 2 post mortem inspection a)
the head and throat; together with palpation and examination of the retropharyngeal lymph node, to ensure the surveillance of the officially tuberculosis free status, may dedice also mouth and fauces
120
official controls on products of animal origin (EU) 2019/627 article 18- young bovine animals - paragraph 2 post mortem inspection b)
the lungs, trachea and oesophagus; palpation of the lungs; palpation and examination of the bronchial and mediastinal lymph nodes (Lnn. bifurcationes, eparteriales and mediastinales)
121
official controls on products of animal origin (EU) 2019/627 article 18- young bovine animals - paragraph 2 post mortem inspection c)
pericardium and hear; diaphragm; the liver and the hepatic and pancreatic lymph nodes, (Lnn. portales); the gastro-intestinal tract, the mesentery and gastric and mesenteric lymph nodes (Lnn. gastrici, mesenterici, craniales and caudales); spleen, kidney, pleura and peritoneum, umbilical region and joints of young animals.
122
official controls on products of animal origin (EU) 2019/627 article 18- young bovine animals - paragraph 3 post mortem incision and palpation general
when there are indications of a possible risk to human health, animal health or animal welfare
123
official controls on products of animal origin (EU) 2019/627 article 18- young bovine animals - paragraph 3 post mortem incision and palpation a)
incision of the retropharyngeal lymph nodes (Lnn. retropharyngiales); palpation of the tongue;
124
official controls on products of animal origin (EU) 2019/627 article 18- young bovine animals - paragraph 3 post mortem incision and palpation b)
incision of the bronchial and mediastinal lymph nodes (Lnn. bifurcationes, eparteriales and mediastinales); lengthwise opening of the trachea and the main branches of the bronchi; the lungs shall be incised in their posterior third, perpendicular to their main axes; these incisions are not necessary where the lungs are excluded from human consumption;
125
official controls on products of animal origin (EU) 2019/627 article 18- young bovine animals - paragraph 3 post mortem incision and palpation c)
lengthways incision of the heart so as to open the ventricles and cut through the interventricular septum;
126
official controls on products of animal origin (EU) 2019/627 article 18- young bovine animals - paragraph 3 post mortem incision and palpation d)
incision of the gastric and mesenteric lymph nodes;
127
official controls on products of animal origin (EU) 2019/627 article 18- young bovine animals - paragraph 3 post mortem incision and palpation e)
palpation of the spleen;
128
official controls on products of animal origin (EU) 2019/627 article 18- young bovine animals - paragraph 3 post mortem incision and palpation f)
incision of the kidneys and the renal lymph nodes (Lnn. renales
129
official controls on products of animal origin (EU) 2019/627 article 18- young bovine animals - paragraph 3 post mortem incision and palpation g)
palpation of the umbilical region and the joints. The umbilical region shall be incised and the joints opened; the synovial fluid must be examined.
130
official controls on products of animal origin (EU) 2019/627 article 18- OTHER bovine animals - paragraph 1 post mortem inspection a)
a visual inspection of the head and throat; INCISION and examination of the retropharyngeal lymph nodes (Lnn. retropharyngiales); examination of the external masseters, in which two incisions shall be made parallel to the mandible, and the internal masseters (internal pterygoid muscles), which shall be incised along one plane. The tongue shall be freed to permit a detailed visual inspection of the mouth and the fauces;
131
official controls on products of animal origin (EU) 2019/627 article 18- OTHER bovine animals - paragraph 1 post mortem inspection b)
an inspection of the trachea and oesophagus; visual inspection and palpation of the lungs; incision and examination of the bronchial and mediastinal lymph nodes (Lnn. bifurcationes, eparteriales and mediastinales);
132
official controls on products of animal origin (EU) 2019/627 article 18- OTHER bovine animals - paragraph 1 post mortem inspection c)
a visual inspection of the pericardium and heart, the latter being INCISED lengthways so as to open the ventricles and cut through the interventricular septum;
133
official controls on products of animal origin (EU) 2019/627 article 18- OTHER bovine animals - paragraph 1 post mortem inspection d)
a visual inspection of the diaphragm; a visual inspection of the liver and the hepatic and pancreatic lymph nodes (Lnn. portales);
134
official controls on products of animal origin (EU) 2019/627 article 18- OTHER bovine animals - paragraph 1 post mortem inspection e)
a visual inspection of the gastro-intestinal tract, the mesentery, the gastric and mesenteric lymph nodes (Lnn. gastrici, mesenterici, craniales and caudales); palpation of the gastric and mesenteric lymph nodes;
135
official controls on products of animal origin (EU) 2019/627 article 18- OTHER bovine animals - paragraph 1 post mortem inspection f)
inspection of the spleen, kidneys, pleura and the peritoneum; genital organs (except for the penis, if already discarded); udder and its lymph nodes (Lnn. supramammarii).
136
official controls on products of animal origin (EU) 2019/627 article 18- OTHER bovine animals - paragraph 3 post mortem incision and palpation a)
an incision and examination of the sub-maxillary and parotid lymph nodes (Lnn. mandibulares and parotidei); palpation of the tongue and the fauces;
137
official controls on products of animal origin (EU) 2019/627 article 18- OTHER bovine animals - paragraph 3 post mortem incision and palpation b)
an incision of the bronchial and mediastinal lymph nodes (Lnn. bifurcationes, eparteriales and mediastinales); lengthwise opening of the trachea and the main branches of the bronchi; the lungs shall be incised in their posterior third, perpendicular to their main axes; these incisions are not necessary where the lungs are excluded from human consumption;
138
official controls on products of animal origin (EU) 2019/627 article 18- OTHER bovine animals - paragraph 3 post mortem incision and palpation c)
a palpation of the liver and the hepatic and pancreatic lymph nodes (Lnn. portales); incision of the gastric surface of the liver and at the base of the caudate lobe to examine the bile ducts;
139
official controls on products of animal origin (EU) 2019/627 article 18- OTHER bovine animals - paragraph 3 post mortem incision and palpation d)
an incision of the gastric and mesenteric lymph nodes; an incision of the kidneys and the renal lymph nodes (Lnn. renales); a palpation of the spleen;
140
official controls on products of animal origin (EU) 2019/627 article 18- OTHER bovine animals - paragraph 3 post mortem incision and palpation e)
a palpation and incision of the udder and its lymph nodes (Lnn. supramammarii) in cows. Each half of the udder shall be opened by a long, deep incision as far as the lactiferous sinuses (sinus lactiferes) and the lymph nodes of the udder shall be incised, except where the udder is excluded from human consumption.
141
official controls on products of animal origin (EU) 2019/627 article 29- Transmissible Spongiform Encephalopaties (TSEs)
official veterinarian shall check the removal, separation and, where appropriate, marking of specified risk material - REMEMBER TSE can be transferred by meat consumption, no evidence for the milk
142
official controls on products of animal origin (EU) 2019/627 article 29- Tubercolosis (TBC) - paragraph 1
positively or inconclusively to tuberculin, or there are other grounds for suspecting infection, they shall be slaughtered separately from other animals - REMEMBER TBC cannot be transferred thorugh meat consumption, it can thorught unpasteurized milk
143
official controls on products of animal origin (EU) 2019/627 article 29- Tubercolosis (TBC) - paragraph 2
All meat from animals in which post-mortem inspection has revealed localised lesions similar to tuberculoid lesions in a number of organs or a number of areas of the carcase shall be declared unfit for human consumption. However, where a tuberculoid lesion has been found in the lymph nodes of only one organ or part of the carcase, only the affected organ or part of the carcase and the associated lymph nodes shall be declared unfit for human consumption.
144
official controls on products of animal origin (EU) 2019/627 article 29- Tubercolosis (TBC) - brucellosis 1
positively or inconclusively to a brucellosis test, or there are other grounds for suspecting infection, they shall be slaughtered separately from other animals, as TBC. REMEMBER BRUC. can be transferred thorugh meat consumption (+), it can thorught unpasteurized (+++)
145
official controls on products of animal origin (EU) 2019/627 article 29- Tubercolosis (TBC) - paragraph 2
Meat from animals in which post-mortem inspection has revealed lesions indicating acute brucellosis shall be declared unfit for human consumption. In the case of animals reacting positively or inconclusively to a brucellosis test, the udder, genital tract and blood shall be declared unfit for human consumption even if no such lesion is found.
146
Regulation (EU) 2019/6 - veterinary medicinal products - Classification of veterinary medicinal products Art 34 -subject to veterinary prescription
narcotic drugs; psychotropic substances; medicinal for food-producing animals; antimicrobial; products for euthanasia; active substance authorised for less than 5 year; immunologica products; substances having a hormonal or thyrostatic action or beta-agonists.
147
Regulation (EU) 2019/6 - veterinary medicinal products - Classification of veterinary medicinal products Art 107 - use of antimicrobial - not for compensation
shall not be applied routinely nor used to compensate for poor hygiene, inadequate animal husbandry or lack of care or to compensate for poor farm management
148
Regulation (EU) 2019/6 - veterinary medicinal products - Classification of veterinary medicinal products Art 107 - use of antimicrobial - not for growth/milk yield
shall not be used in animals for the purpose of promoting growth nor to increase yield.
149
Regulation (EU) 2019/6 - veterinary medicinal products - Classification of veterinary medicinal products Art 107 - use of antimicrobial - prophylaxis
shall not be used for prophylaxis other than in exceptional cases, for the administration to an individual animal or a restricted number of animals when the risk of an infection or of an infectious disease is very high and the consequences are likely to be severe
150
Regulation (EU) 2019/6 - veterinary medicinal products - Classification of veterinary medicinal products Art 107 - use of antimicrobial - metaphylaxis
shall be used for metaphylaxis only when the risk of spread of an infection or of an infectious disease in the group of animals is high and where no other appropriate alternatives are available
151
Regulation (EU) 2019/6 - veterinary medicinal products - Classification of veterinary medicinal products Art 110 - use of immunological producs - limitations
can be decided if the products may interfere with national programme for the diagnosis, control or eradication of animal diseases; when may cause difficulties in certifying the absence of disease; strains of disease agents are absent in the territory concerned
152
Regulation (EU) 2019/6 - veterinary medicinal products - Classification of veterinary medicinal products Art 111 - Use of veterinary medicinal products in other Member States - authorization
A veterinarian providing services in a Member State shall be allowed to possess and administer veterinary medicinal products which are not authorised in the host Member State.
153
Regulation (EU) 2019/6 - veterinary medicinal products - Classification of veterinary medicinal products Art 111 - Use of veterinary medicinal products in other Member States - condition for use
The quantitative not exceeding the amount required for the treatment prescribed; a marketing authorisation for the medicinal product; products transported in their original packaging; follows the good veterinary practice applied in the host Member State; sets the withdrawal period specified on the labelling or package leaflet; the veterinarian does not retail any veterinary medicinal product unless this is permissible under the rules of the host Member State
154
Regulation (EU) 2019/6 - veterinary medicinal products - Classification of veterinary medicinal products Art 113 - extralabel use
Allowed use of products authorised i the relevant Member State or in another Member State for use: a) in the same or in another food-producing terrestrial animal for the same indication, or for another indication; b) for use in a non-food-producing animal species for the same indication; product for human if there are not products indicated with a) and b) points; product prepared extemporaneously is point a), b) and c) are not verified.
155
Regulation (EU) 2019/6 - veterinary medicinal products - Classification of veterinary medicinal products Art 113 - extralabel use - Third countries
Except as regards immunological veterinary medicinal products, where there is no medicinal product available the veterinarian responsible may exceptionally treat food-producing terrestrial animals with a veterinary medicinal product authorised in a third country for the same animal species and same indication.
156
Regulation (EU) 2019/6 - veterinary medicinal products - Classification of veterinary medicinal products Art 113 - extralabel use - adminitration
The veterinarian may administer the medicinal product personally or allow another person to do so under the veterinarian’s responsibility, in accordance with national provisions.
157
Regulation (EU) 2019/6 - veterinary medicinal products - Classification of veterinary medicinal products Art 115 - Withdrawal period for products used outside the terms of authorisation - MEAT
the longest withdrawal period provided in its summary of the product multiplied by factor 1,5; 28 days if not authorised for food-producing animals; one day; 1 day, if the product has a 0 withdrawal period and is used in a different taxonomic family than the target species authorised
158
Regulation (EU) 2019/6 - veterinary medicinal products - Classification of veterinary medicinal products Art 115 - Withdrawal period for products used outside the terms of authorisation - MILK
the longest withdrawal period provided in its summary of the product multiplied by factor 1,5; 7 days, if the medicinal product is not authorised for animals producing milk for human consumption; 1 day, if the medicinal product has a 0 withdrawal period
159
Regulation (EU) 2019/6 - veterinary medicinal products - Classification of veterinary medicinal products Art 116 - Health situation - Derogation article 106
Competent authority may allow the use in its territory of veterinary medicinal products not authorised in that Member State, where the situation of animal or public health so requires, and the marketing of those veterinary medicinal products is authorised in another Member State
160
Regulation (EU) 2016/429 - Transmissible diseases - animals health law - list of diseases
foot and mouth disease; Rinderpest (cattle plague); Bluetongue; Lumpy skin disease; Vesicular stomatitis; Contagious bovine pleuropneumonia; Bovine tuberculosis; Bovine brucellosis (B. abortus) Anthrax; Rabies; Echinococcosis; Transmissible spongiform encephalopathies (TSE); Listeriosis — Salmonellosis (zoonotic salmonella); Verotoxigenic E. coli
161
Regulation (EU) 2016/429 - Transmissible diseases - animals health law - art 9- Disease prevention and control rules - applicatiion
diseases do not normally occur in the Union that require immediate eradication; diseases that need control with the goal of eradicating; diseases relevant for some Member States and for which measures are needed to prevent them from spreading that are officially disease-free or that have eradication programmes ; diseases for which measures are needed to prevent them from spreading on account of their entry into the Union or movements; diseases for which there is a need for surveillance within the Union,
162
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 36.- Disease–free Member States and zones - Definitions
none of the listed species for the disease covered is present; the disease agent is known not to be able to survive; in the case of listed diseases only transmitted by vectors, none of the vectors are present, freedom from the listed disease has been demonstrated by eradication program or historical/surveillance data
163
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 36.- Disease–Suspension, withdrawal, restoration of disease–free status
any of the conditions for maintaining its status as a disease–free Member State or zone or compartment thereof, have been breached is necessary to suspend or restrict movements of the listed species and to apply the disease control measures
164
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 46.- Disease–medicinal products for disease prevention and control
The Member States may take measures concerning the use of veterinary medicinal products for listed diseases, to ensure the most efficient prevention or control of those diseases, provided that such measures are appropriate or necessary.
165
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 48.- Disease– establishment of Union antigen, vaccine and diagnostic reagent
For listed diseases in respect of which vaccination is not prohibited the Commission may establish banks for the storage of: (a) antigens; (b) vaccines; (c) vaccine master seed–stocks; (d) diagnostic reagents
166
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 53.- Disease– Obligations on operators
In the event of suspicion of a listed disease in kept animals, operators and other relevant natural and legal persons concerned take the appropriate disease control measures to prevent the spread of that listed disease
167
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 54.- Disease– Investigation by the competent authority
official veterinarians carry out a clinical examination of a representative sample of the kept animals; take appropriate sample
168
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 55-77.- Disease–Preliminary control measures
place the establishment compile an inventory of: the kept animals in the establishment,
169
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 58 -80 - Disease–official confirmation
Official confirmation of a listed disease is based on clinical and laboratory examinations; results of the epidemiological enquiry;other available epidemiological data.
170
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 60 - Disease–Immeditate disease control measures
declare the affected establishment; establish a restricted zone appropriate; implement the contingency plan provided , for control measure consider profile of the disease, kept animals affected; economic and social impact of the disease
171
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 61 - Disease–Affected establishments and other locations
In the event of an outbreak imposition of restrictions on movements of persons, animals, the killing and disposal or slaughtering of animals that may be contaminated or contribute to the spread of the listed disease, the vaccination or treatment if allowed, the isolation, quarantine of the animals, sampling for epidemiological investigations
172
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 64 - Disease–Establishment of restricted zones
where appropriate taking into account: a) disease profile; (b) the geographical situation; (c) the ecological and hydrological factors; (d) the meteorological conditions; (e) the presence, distribution and type of vectors; (f) the results of the epidemiological enquiry, (g) the results of laboratory tests; (h) the disease control measures applied; B221(i) other relevant epidemiological factors. The restricted zone shall include, when appropriate, a protection and surveillance zone of a defined size and configuration.
173
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 66 - Disease–Operators' obligations regarding movements in restricted zones
operators shall only move the kept animals and products with the permission of the competent authority and in accordance with any instructions given by that authority.
174
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 108 - 109 - Disease– system for the identification and registration of kept terrestrial animals
Member States shall have in place a system for the identification and registration of those species of kept terrestrial animals, including species or categories, risk posed by the specie, registration have to be on a informatic database
175
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 112 - Disease– Operators' obligations in respect of the identification of kept animals of the bovine species
ensure that those kept animals are identified individually by a physical means of identification, when they are moved between Member States, are issued with an identification document (correctly written and that follow the animals in all their movements); transmit the information on movements of those kept animals from and to the establishment concerned, and all births and deaths in that establishment
176
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 121 - Disease– obligations for germinal products
Operators producing, processing or storing germinal products shall mark germinal products of kept animals have to leave clearly trace of the donor animals, date of collection, establishments where they were collected, produced, processed and stored.
177
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 124 - Disease– General requirements for movements
Movements possible if not affected by listed diseases referred to in point (d) of Article 9(1) or emerging diseases.
178
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 125 - Disease– Disease prevention measures in relation to transport
health status not at risk during transport; transport do not cause the potential spread of listed diseases, apply biosecurity measure to reduce risk of infection due to transport operations,
179
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 126 - Disease– movements between Member States - part 1
if the animals fulfil the following conditions: no disease symptoms, come from a registered or approved establishment with no abnormal mortalities with an undetermined cause or is not subject to movement restrictions affecting the species, which is not situated in a restricted zone.
180
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 126 - Disease– movements between Member States -part 2
if the animals fulfil the following conditions: They have not been in contact with kept terrestrial animals which are subject to movement restriction or kept terrestrial animals of a listed species of a lower health status, for an adequate period of time prior to the date of the intended movement to another Member State, thereby minimising the possibility of spreading disease
181
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 128 - Disease– Prohibition on movements outside the territory of a Member State
Operators shall not move kept terrestrial animals intended to be slaughtered for disease eradication purposes as part of an eradication programm to another Member State unless the Member State of destination and, where relevant, the Member State of passage authorise the movement in advance.
182
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 130 - Disease– Specific requirements in respect of movements to other Member Sta tes of ungulates
if the animals in question fulfil the following conditions as regards the listed diseases art9 letter d): no clinical signs, subject to a residency period appropriate, no ungulates have been introduced into the establishment for a period of time appropriate, they are presumed not to pose a significant risk of spreading considering health status, results of laboratory, application of vaccination or other disease prevention or risk-mitigation measures
183
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 134 - Disease– Kept ungulates moved to another Member State and intended for slaughter - assembly operations
kept ungulates assembled have the same health status; where they do not, the lower health status applies to all such animals assembled; moved to their final place ASAP,take biosecurity measures (no contacts with lower health status), kept ungulates identified
184
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 143 - health certification
shall only move ungulates to another Member State if the animals in question are accompanied by an animal health certificate issued by the competent authority
185
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 145 - Contents of animal health certificates
establishment or place of origin, the establishment or place of destination and, where relevant, establishments for assembly operations or for rests, means of transport and the transporter; description and numebr of the terrestrial animal, identification and registration of kept terrestrial animals; information needed to demonstrate that the kept terrestrial animals fulfil the relevant animal health requirements
186
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 157 - Disease– General requirements for movements germinal material
Movements possible if not affected by listed diseases referred to in point (d) of Article 9(1) or emerging diseases and come from center registered and approved.
187
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 159 - Disease– Obligations in respect of movements to other Member States of germinal products
e collected, produced, processed and stored in germinal product establishments approved in such a way as to ensure that they do not spread listed diseases as referred to in point (d) art 9; collected from donor animals which fulfil the necessary animal health requirements fro listed diseases;
188
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 161 - Disease– Certification of movements for germinal products
such products are accompanied by an animal health certificate (also if it is moved from restricted zone)
189
Regulation (EU) 2016/429 - Transmissible diseases - animals health law -art 162 - Disease– Content of animal health certificates for germinal products
germinal product establishment of origin and the establishment or place of destination; type of the germinal products and the species; volume or number of the germinal product; the marking of the germinal products; the information needed to demonstrate that the germinal products of the consignment fulfil the movement requirements for the relevant species
190
191
Overall Animal welfare regulation_instrument to impose standards
Farming activities are covered by five directives (2 of them for cows) which impose minimum standards while the transport and the killing of animals are covered by regulations which set up similar requirements for all Member States
192
Directive 98/581: All farmed animals
contains very general requirements (staff, record keeping, freedom of movement, accommodation, equipment, feed and water, mutilations and breeding procedures)
193
Directive 2008/1193: Calves
The requirements focus on accommodation standards, in particular by introducing group housing for calves older than eight weeks of age; e directive forbids keeping calves in permanent darkness and tethering. It also requires a balanced diet adapted to the needs of the calves by providing progressively fibrous food and sufficient iron. Muzzling is also forbidden.